On January 24, 2023, Legend Biotech Corporation (NASDAQ: LEGN) opened at $54.23, higher 0.46% from the last session. During the day, the shares moved up to $55.60 and dropped to $49.53 before settling in for the closing price of $53.98. Price fluctuations for LEGN have ranged from $30.75 to $57.72 over the past 52 weeks.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Company’s average yearly earnings per share was noted -20.20% at the time writing. With a float of $165.11 million, this company’s outstanding shares have now reached $167.40 million.
In an organization with 1071 employees, it is important to assess its efficiency.
Legend Biotech Corporation (LEGN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Legend Biotech Corporation is 1.37%, while institutional ownership is 38.80%.
Legend Biotech Corporation (LEGN) Latest Financial update
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.13 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.46) by $0.33. This company achieved a net margin of -430.12 while generating a return on equity of -102.79. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.20% per share during the next fiscal year.
Legend Biotech Corporation (NASDAQ: LEGN) Trading Performance Indicators
Check out the current performance indicators for Legend Biotech Corporation (LEGN). In the past quarter, the stock posted a quick ratio of 3.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 78.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.34, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.55 in one year’s time.
Technical Analysis of Legend Biotech Corporation (LEGN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.69 million. That was inferior than the volume of 0.75 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 65.05%. Additionally, its Average True Range was 3.03.
During the past 100 days, Legend Biotech Corporation’s (LEGN) raw stochastic average was set at 82.91%, which indicates a significant increase from 69.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.74% in the past 14 days, which was higher than the 46.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.27, while its 200-day Moving Average is $46.50. However, in the short run, Legend Biotech Corporation’s stock first resistance to watch stands at $56.71. Second resistance stands at $59.19. The third major resistance level sits at $62.78. If the price goes on to break the first support level at $50.64, it is likely to go to the next support level at $47.05. The third support level lies at $44.57 if the price breaches the second support level.
Legend Biotech Corporation (NASDAQ: LEGN) Key Stats
There are currently 164,092K shares outstanding in the company with a market cap of 9.13 billion. Presently, the company’s annual sales total 92,850 K according to its annual income of -386,210 K. Last quarter, the company’s sales amounted to 40,827 K and its income totaled -41,087 K.